compani trade less week
unless otherwis note metric base modelwar
base consensu methodolog
consensu data provid thomson reuter estim
impact view maintain uw rate stock trade
line peer standard ev/ebitda despit lower top-lin
growth ntm organ vs peer manag re-affirmed
guidanc lower specif segment guidanc ipreo expect come
low end revenu rang low-single-digit growth vs
low- mid-single-digit prior financi market revenu miss mse driven
lower ipreo revenu impact lower equiti issuanc
quarter impact custom consolid lead delay around
contract renew contract offici lost point
resourc exceed estim organ growth though benefit
account chang rais pt follow
model updat roll-forward estim
recap miss mse top-lin adj ebitda beat adj ep due
tax benefit post strong quarter grow organ
subscript organ growth non-subscript organ growth
transport organ growth subscript organ growth
non-subscript organ growth financi servic organ vs
mse driven strong solut growth process grew
organ continu impact depress primari loan issuanc
market partial off-set strong deriv process ipreo disappoint
post revenu vs mse primarili driven lower equiti
issuanc quarter caus govern shutdown organ
revenu declin affect tmt contract renew delay prior year
boiler code revenu compar adj ebitda margin solid
expand
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
sell gener administr ex sbc
total revenu
restructur offer acquisit cost credit
incom equiti investment/shar jv/other
net incom common stockhold
risk/reward unfavor downsid pt
risk/reward unfavor downsid pt
deriv discount cash flow valuat wacc
risk-fre rate market risk premium beta
termin growth rate base case
organ revenu growth compound-annual-growth-rate adj ebitda margin
encompass higher growth rate oper margin base
case full credit target revenu cost synergi
organ revenu growth compound-annual-growth-rate adj ebitda margin
growth lacklust energi environ
continu moder margin benefit scale acquisit synergi
credit half revenu full cost synergi
organ revenu growth compound-annual-growth-rate adj ebitda margin
encompass lower growth across industri vertic especi
lower oper margin base case credit
revenu cost synergi
uw lead supplier
inform servic across multipl
vertic attract busi model
believ current elev valuat
standard ev/ebitda
adequ reflect averag organ
growth dcf-base pt
impli downsid current level
product absenc substitut lead
margin expans driven cost synergi
scale platform initi
develop geograph penetr
capit return repurchas
share though halt
program delev ipreo
acquisit reach target
loan issuanc trade volum
auto industri slowdown acceler
risk achiev price
better-than worse-than-expect
exhibit quarterli revenu segment
exhibit statement flow
valuat methodolog risk
price target deriv discount cash flow valuat wacc
risk-fre rate market risk premium beta termin growth
rate base case risk achiev price target includ
better-than worse-than-expect capital-expenditure trend could drive higher/low
